Advertisement
Research Article Free access | 10.1172/JCI105787
1Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514
Find articles by Sachs, J. in: JCI | PubMed | Google Scholar
1Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514
Find articles by Welt, L. in: JCI | PubMed | Google Scholar
Published April 1, 1968 - More info
The active potassium influx in the human red blood cell is inhibited by strophanthidin, ethacrynic acid, and MK-870 (a new diuretic), and the degree of inhibition is greater at low concentrations of extracellular potassium than at high. In the case of ethacrynic acid, potassium appears to diminish the rate of combination of the drug with the transport system. The kinetic behavior of the active potassium influx in the presence of the inhibitors strophanthidin and ethacrynic acid is consistent with a model in which the binding of potassium at one of the potassium-sensitive sites in the transport system reduces the affinity of the system for the drug, and binding of a second potassium ion further reduces the affinity. It is not possible to distinguish between the sites on the basis of the studies presented here.